Skip to main content

Prevention

What's new

During an immensely challenging and unprecedented year, diaTribe continued to create, curate, and publish helpful information for people with diabetes – read our twelve most popular articles of the year. Highlights include intermittent fasting, how to navigate the COVID-19 pandemic with diabetes, and the latest in diabetes tech. Continue Reading »

Average A1C values differ between racial and ethnic groups – people of color have a higher average A1C compared to white people. This is because someone’s A1C value could potentially reflect more than just their average glucose level. A1C values are also influenced by differences in survival rates of red blood cells and how sugar attaches to them.  In addition, because A1C does not provide any specific information about glucose variability or hypoglycemia, it is important to consider using other personalized metrics to better assess diabetes care. Continue Reading »

T1Detect is JDRF’s new universal type 1 diabetes screening initiative. The screening test will be completed at home and available to people in the United States. Continue Reading »

Recent results from Omada Health’s Digital Diabetes Prevention Program show reductions in A1C and body weight over a 12-month period. This digital tool may be especially helpful for people with prediabetes during COVID-19 Continue Reading »

Health experts are recommending more than ever that people with diabetes get their flu shot this year to reduce the chances of getting sick with both flu and COVID-19. Learn about your vaccine options, where to get them, and how the flu can affect people with diabetes Continue Reading »

GLP-1 agonists are a class of drug recommended for people with type 2 diabetes to lower glucose and body weight, and for heart and stroke protection in those with heart disease. Learn more about these medicines, including their side effects, how they work, and their role in diabetes and heart health Continue Reading »

More people with diabetes are taking drugs like Jardiance and Farxiga, originally developed to lower glucose in people with type 2 diabetes, because the latest data confirms that these drugs can protect your kidneys. A therapy still under investigation, finerenone, has been developed to protect the kidneys of people with and without diabetes Continue Reading »

SGLT-2 inhibitors can protect your heart! This type of medicine is recommended for people with type 2 diabetes who have heart disease or risk factors related to heart disease. Learn about the use of these medicines, including side effects, their effect on A1C, and their role in supporting heart health Continue Reading »

Pages